Health Catalyst
HCAT
Health Catalyst (HCAT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.04
- EPS estimate
- $0.03
- EPS surprise
- +33.78%
- Revenue surprise
- +2.02%
- Revenue
- $70.5M
- Revenue estimate
- $69.1M
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.03 | $0.04 | +33.78% | $70.5M | SEC |
| Q1 2026 | May 11, 2026 | $0.01 | $0.02 | +80.18% | $70.8M | SEC |
| Q4 2025 | Mar 12, 2026 | $0.09 | $0.08 | −15.07% | $74.7M | SEC |
| Q3 2025 | Nov 10, 2025 | $0.06 | $0.06 | −1.96% | $76.3M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.03 | $0.04 | +22.32% | $80.7M | SEC |
| Q1 2025 | May 7, 2025 | −$0.00 | $0.01 | +470.37% | $79.4M | SEC |
| Q4 2024 | Feb 26, 2025 | $0.07 | $0.04 | −45.21% | $79.6M | SEC |
| Q3 2024 | Nov 6, 2024 | $0.10 | $0.07 | −27.39% | $76.4M | SEC |
| Q2 2024 | Aug 7, 2024 | $0.08 | $0.12 | +49.81% | $75.9M | SEC |
| Q1 2024 | May 9, 2024 | $0.03 | $0.05 | +62.34% | $74.7M | SEC |
| Q4 2023 | Feb 22, 2024 | $0.01 | $0.02 | +70.94% | $75.1M | SEC |
| Q3 2023 | Nov 2, 2023 | −$0.00 | $0.03 | +1171.43% | $73.8M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.01 | $0.05 | +562.96% | $73.2M | SEC |
| Q1 2023 | May 9, 2023 | −$0.04 | $0.05 | +235.87% | $73.9M | SEC |
| Q4 2022 | Feb 28, 2023 | −$0.11 | −$0.05 | +55.36% | $69.2M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.19 | −$0.13 | +31.43% | $68.4M | SEC |
| Q2 2022 | Aug 4, 2022 | −$0.10 | −$0.03 | +68.55% | $70.6M | SEC |
| Q1 2022 | May 10, 2022 | −$0.11 | −$0.06 | +43.98% | $68.1M | SEC |
| Q4 2021 | Mar 1, 2022 | −$0.21 | −$0.19 | +10.29% | $64.7M | SEC |
| Q3 2021 | Nov 9, 2021 | −$0.22 | −$0.18 | +17.20% | $61.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Health Catalyst (HCAT) last report earnings?
Health Catalyst last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did HCAT beat earnings estimates?
Yes. Health Catalyst reported EPS of $0.04 for Q2 2026 against a $0.03 estimate — a 33.78% beat.
How much revenue did HCAT report last quarter?
Health Catalyst reported $70.5M in revenue for Q2 2026, against a consensus estimate of $69.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.